University of South Florida H. Lee Moffitt Cancer Center & Research Inst.
Welcome,         Profile    Billing    Logout  
 7 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jain, Rohit
KEYNOTE-D78, NCT04879329: A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Recruiting
2
332
Europe, Canada, Japan, US, RoW
disitamab vedotin, RC48-ADC, pembrolizumab, KEYTRUDA®
Seagen Inc., Merck Sharp & Dohme LLC
Urothelial Carcinoma
11/26
05/28
CA209-63Y, NCT04863885: Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients

Checkmark Data from trial in combination with Ipilimumab and Nivolumab for Urothelial Carcinoma at ESMO 2021
Jul 2021 - Jul 2021: Data from trial in combination with Ipilimumab and Nivolumab for Urothelial Carcinoma at ESMO 2021
Active, not recruiting
1/2
46
US
Ipilimumab, Yervoy, Nivolumab, Opdivo, Sacituzumab govitecan, Trodelvy
H. Lee Moffitt Cancer Center and Research Institute, Bristol-Myers Squibb, Gilead Sciences
Metastatic Urothelial Carcinoma
04/26
04/27
MCC-22344, NCT06193486: Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC

Recruiting
1
30
US
MSGV1-PSCA-8T28Z, Fludarabine, Fludara, Cyclophosphamide
H. Lee Moffitt Cancer Center and Research Institute
Metastatic Castration-resistant Prostate Cancer
01/29
12/33
NCT04963153: Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy

Recruiting
1
30
Canada, US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Scan, Bone Scintigraphy, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Echocardiography, EC, Enfortumab Vedotin, AGS 22ME, AGS-22M6E, Anti-Nectin 4 ADC ASG-22CE, Anti-nectin-4 Monoclonal Antibody-Drug Conjugate AGS-22M6E, ASG 22CE, ASG-22CE, ASG22CE, Enfortumab Vedotin-ejfv, Padcev, Erdafitinib, Balversa, JNJ 42756493, JNJ-42756493, JNJ42756493, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNV Scan, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning
National Cancer Institute (NCI)
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma, Locally Advanced Urethral Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma, Metastatic Renal Pelvis Urothelial Carcinoma, Metastatic Ureter Urothelial Carcinoma, Metastatic Urethral Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Recurrent Bladder Urothelial Carcinoma, Recurrent Renal Pelvis Urothelial Carcinoma, Recurrent Ureter Urothelial Carcinoma, Recurrent Urethral Urothelial Carcinoma, Recurrent Urothelial Carcinoma, Stage IIIB Bladder Cancer AJCC v8, Stage IV Bladder Cancer AJCC v8, Stage IV Renal Pelvis Cancer AJCC v8, Stage IV Ureter Cancer AJCC v8, Stage IV Urethral Cancer AJCC v8
09/25
09/25
NCT03837821: (CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer

Active, not recruiting
1
20
US
Abemaciclib
Weill Medical College of Cornell University, Eli Lilly and Company
Bladder Cancer
07/24
12/25
MCC-20575, NCT04610671: Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC

Active, not recruiting
1
21
US
CG0070, Nivolumab
H. Lee Moffitt Cancer Center and Research Institute, CG Oncology, Inc., Richard M. Shulze Family Foundation
Muscle-Invasive Bladder Carcinoma, Bladder Cancer
01/25
01/26
NCT05367518: Colonisation Efficacy of Oral Probiotic Fast Melt Powder

Recruiting
N/A
20
RoW
Probiotic Streptococcus salivarius K12 Fast Melt Powder 1 Billion colony forming units /g), Probiotic Streptococcus salivarius K12 Fast Melt Powder 100 Million colony forming units /g)
BLIS Technologies Limited
Microbial Colonization
05/22
06/22
NCT05375396: Microbial Colonization of Dairy Free Oral Probiotics

Recruiting
N/A
30
RoW
Streptococcus salivarius M18 lozenges, Streptococcus salivarius M18 dairy free lozenges
John Hale
Microbial Colonization
07/22
08/22
NCT05375383: Microbial Colonization of Oral Probiotics

Recruiting
N/A
60
RoW
Streptococcus salivarius K12 lozenge, Probiotic S. salivarius K12 lozenges containing prebiotic A, Probiotic S. salivarius K12 lozenges containing prebiotic B, Probiotic S. salivarius K12 lozenges containing prebiotics A and B, Probiotic S. salivarius K12 powder, Probiotic S. salivarius K12 powder containing prebiotic A, Probiotic S. salivarius K12 powder containing prebiotic B, Probiotic S. salivarius K12 powder containing prebiotics A and B, Probiotic S. salivarius M18 lozenges, Probiotic S. salivarius M18 lozenges containing prebiotic A, Probiotic S. salivarius M18 lozenges containing prebiotic B, Probiotic S. salivarius M18 + lozenges containing prebiotic A and B
BLIS Technologies Limited
Microbial Colonization
08/22
09/22
NCT05480020: Probiotic Toothpaste for Microbial Colonization

Recruiting
N/A
30
RoW
Streptococcus salivarius M18 toothpaste
John Hale
Microbial Colonization
09/22
10/22
NCT05750381: Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Balm in Healthy Adults.

Recruiting
N/A
20
RoW
Micrococcus luteus Blis Q24 balm, Placebo balm
BLIS Technologies Limited
Microbial Colonization
03/23
04/23

Download Options